ANI Pharmaceuticals Inc
NASDAQ:ANIP 4:00:00 PM EDT
| Market Cap (Intraday) | 1.23B |
| Current PE | 45.64 |
| Forward PE | 12.47 |
| 2yr Forward PE | 11.14 |
| 10-Day MA | $57.56 |
| 50-Day MA | $59.31 |
| 200-Day MA | $61.81 |
ANI Pharmaceuticals Inc Stock, NASDAQ:ANIP
210 Main Street West, Baudette, Minnesota 56623
United States of America
Phone: +1.218.634.3500
Number of Employees: 642
Description
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.